Arcosa Inc
Statements
Cash Flow
Arcosa Inc (ACA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -11 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 228 | 65 | 29 | 41 | 28 | 90 | 9.5 | 19 | -0.1 | 125 | 16 | 78 | 140 | 42 | 79 | 106 | 33 | 0.4 | 51 | 26 | 90 | 25 | 87 | 71 | -8.3 | 27 | 128 | 44 | 62 | 81 | 38 | 135 | 248 | -0.7 | 61 | 161 | 120 | 72 | -11 | 341 | |
| 66 | 16 | 15 | 17 | 18 | 17 | 16 | 17 | 18 | 20 | 22 | 22 | 23 | 27 | 27 | 28 | 60 | 31 | 37 | 35 | 115 | 38 | 77 | 40 | 77 | 39 | 4.0 | 4.1 | 41 | 43 | 47 | 45 | 195 | 54 | 110 | 56 | 57 | 54 | 58 | 225 | |
| – | 2.1 | 2.3 | 2.3 | 2.3 | 2.2 | 2.6 | 2.7 | 2.4 | 3.4 | 3.7 | 4.0 | 3.5 | 3.7 | 5.1 | 5.2 | 6.0 | 4.7 | 4.1 | 4.0 | 5.2 | 4.4 | 5.7 | 5.4 | 3.6 | 5.5 | 7.1 | 5.7 | 5.6 | 6.7 | 7.4 | 4.9 | 5.3 | 6.7 | 6.7 | 6.4 | 6.6 | 6.3 | 6.0 | 25 | |
| 29 | -1.6 | 2.9 | 6.7 | 7.1 | 5.2 | 5.7 | 39 | 6.0 | 5.2 | 6.5 | 9.8 | 2.3 | -8.1 | -3.4 | 28 | 15 | 2.3 | -1.1 | -2.6 | 6.8 | 8.8 | 9.8 | 3.6 | -166 | -13 | 11 | -2.7 | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | 20 | -11 | -3.0 | -13 | 45 | -35 | -40 | -52 | 74 | -46 | 14 | 93 | -23 | 16 | 42 | -27 | -47 | -5.6 | -36 | 36 | -42 | -1.6 | -3.8 | -31 | -55 | 41 | -29 | -32 | 4.6 | -49 | 50 | 180 | -81 | -76 | 23 | -21 | -36 | 23 | -10 | |
| 85 | 18 | 14 | 14 | 37 | 7.6 | 13 | 13 | 12 | 18 | 21 | 22 | 24 | 21 | 23 | 13 | 25 | 20 | 22 | 19 | 24 | 26 | 27 | 33 | 52 | 44 | 53 | 48 | 59 | 54 | 48 | 34 | 53 | 34 | 28 | 40 | 64 | 44 | 59 | 206 | |
| -80 | -17 | -18 | -56 | -35 | -32 | -12 | -11 | -309 | -17 | -42 | -28 | -22 | -325 | -25 | -59 | -119 | -10 | -409 | -150 | -1.0 | -5.3 | -93 | -31 | 91 | -34 | -52 | -132 | -154 | -44 | -198 | -9.4 | -1,258 | -11 | -22 | -27 | -61 | -98 | 379 | 193 | |
| – | – | – | – | – | – | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.4 | 2.5 | 2.5 | 2.4 | 2.4 | 2.5 | 2.4 | 2.5 | 2.5 | 2.4 | 2.4 | 2.6 | 2.4 | 2.4 | 2.4 | 2.4 | 2.5 | 2.5 | 2.4 | 2.5 | 2.4 | 2.4 | 2.5 | 2.5 | 2.5 | 2.5 | 2.4 | 2.5 | 9.9 | |
| – | – | – | – | – | – | – | – | -3.5 | -6.2 | -5.9 | -3.0 | -0.3 | -2.0 | -3.3 | -2.2 | -4.3 | -0.1 | -14 | -4.9 | -0.5 | -0.1 | -25 | -0.1 | -2.7 | -0.1 | -11 | -11 | -14 | -1.2 | -9.2 | -0.1 | -0.1 | -1.5 | -11 | -12 | -0.5 | -18 | -1.1 | -32 | |
| -0.5 | 0.6 | 0.6 | -0.1 | 0.5 | -0.1 | -0.1 | 180 | 180 | -80 | -0.3 | -0.3 | -0.2 | 250 | -100 | -2.0 | -1.1 | -1.4 | 400 | 98 | -86 | -1.0 | 25 | -3.5 | -160 | -1.9 | -3.5 | -37 | – | – | – | 538 | 458 | -3.3 | -3.3 | -101 | -61 | -2.4 | -85 | -250 | |
| -144 | -51 | -8.9 | 13 | 4.0 | -58 | 6.8 | -8.5 | 398 | -89 | -8.7 | -5.7 | -4.9 | 244 | -106 | -6.6 | -7.9 | -3.9 | 376 | 90 | -82 | -3.5 | -2.5 | -6.0 | -166 | -4.4 | -27 | -41 | 42 | 35 | 87 | 528 | 441 | -7.3 | -17 | -104 | -64 | -35 | -89 | -292 | |
| 3.8 | -3.5 | 1.4 | -1.7 | -3.4 | -0.1 | 3.9 | -0.2 | 89 | 19 | -35 | 44 | 113 | -40 | -52 | 41 | -93 | -14 | 18 | -34 | 6.8 | 16 | -9.2 | 35 | 46 | -11 | 49 | -43 | -51 | 72 | -73 | 653 | -570 | -19 | 22 | 30 | -5.4 | -61 | 279 | 242 | |
| – | 46 | 15 | 27 | -8.8 | 82 | -3.3 | 6.8 | -12 | 107 | -4.7 | 56 | 115 | 20 | 56 | 93 | 8.0 | -20 | 29 | 6.4 | 65 | -1.4 | 60 | 38 | -60 | -17 | 75 | -4.0 | 3.5 | 26 | -9.3 | 101 | 195 | -35 | 33 | 121 | 56 | 28 | -70 | 135 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.